← Eichor
Study identifier: NCT05655897 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation

Condition: Mitral Regurgitation · Degenerative Mitral Valve Disease  ·  Sponsor: Peijia Medical Technology (Suzhou) Co., Ltd.

PhaseNA
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To observe and evaluate the safety and efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation through a prospective, multicenter clinical trial using objective performance criteria.

This description comes directly from the study's public registry record.

Talk to the study team

Jinjin Zhang  ·  +86-13814870113  ·  jameszhang@peijiamedical.com

Always discuss trial participation with your own doctor first.

Locations (1)

Peiga Medical Technology (Suzhou) Co.Suzhou, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05655897